A fusion protein of endothelial cell growth factor and its application in regenerative medicine
A technology of fusion protein and growth factor, applied in the field of genetic engineering, can solve the problems of loss of inherent biological activity of growth factor, the biological activity of VEGF needs to be improved, and the immobilization and release behavior of VEGF cannot be quantitatively regulated, so as to improve the anticoagulant performance. , Improve angiogenesis-inducing ability, and promote the effect of rapid endothelialization
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0035] Example 2
[0036] The plasmid pcDNA3.1-VEGF-Fc containing the target gene constructed in Example 1 was transfected into 293F cells, the cell supernatant was collected, and the VEGF-Fc fusion protein was purified using rProtein A FF column. The purified fusion protein was detected by immunoblotting with an anti-VEGF antibody, and there were no other non-specific exposure bands in the figure, only one band similar to the expected molecular weight (46KD). This result shows that the present invention has prepared VEGF-Fc fusion protein ( image 3 ). The resulting fusion protein is used to modify the surface of the hydrophobic material to form an endothelial cell growth factor fusion protein matrix for endothelial cell culture, as shown in the schematic diagram ( Figure 4 ) shown.
Embodiment 2
[0038] Example 3
[0039] The invention detects the adhesion of endothelial cells on the surface of differently modified polystyrene culture dishes by MTT method, and then investigates the effect of VEGF-Fc fusion protein matrix on the adhesion of endothelial cells.
Embodiment 3
[0041]
[0042] Example 4
[0043] In the present invention, it is further shown by cell proliferation experiments that compared with the addition of VEGF in the solution, the addition of VEGF-Fc fusion protein in the solution can effectively promote the proliferation of endothelial cells and the VEGF-Fc fusion protein can better maintain the cells with the prolongation of culture time. proliferative activity ( Figure 6 ). We can conclude that VEGF-Fc fusion protein can effectively prolong the biological activity of VEGF in vitro, and VEGF-Fc fusion protein matrix can promote endothelial cell proliferation persistently.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com